Acute treatment of migraine has benefited first from major advances in pharmacological science followed in short order, sometimes preceded, by an improved understanding of pathogenesis, especially of headache. This chapter reviews the mechanisms of migraine that provide an understanding of the pharmacology...
Learn about REYVOW® (C-V), a medication for the acute treatment of migraine attacks when they happen.
Learn about UBRELVY® (ubrogepant), an acute treatment for migraine in adults. It’s not for migraine prevention. See full Safety and Prescribing Info.
The acute treatment of migraine includes specific drugs, which currently all have vasoconstrictive effects (dihydroergotamine and triptans), and nonspecific drugs that include paracetamol (acetaminophen), combination analgesics, non-steroidal anti-inflammatory drugs (NSAIDs), dopamine antagonists, narcotics ...
Acute Treatment of Migraine. This article provides a framework to help providers formulate a plan for the acute treatment of migraine. Topics covered include the cost-effective patient... Bert,B,Vargas - 《Continuum》 被引量: 5发表: 2018年 Haloperidol in the Acute Treatment of Migraine: A ...
Guidelines for the acute pharmacological treatment of migraine were published in August 2024 by the International Headache Society (IHS) inCephalalgia.1] For individuals with migraine who do not respond to analgesics or non-steroidal anti-inflammatory drugs (NSAIDs) taken at appropriate doses early ...
Why do migraine treatments fail? Here are some reasons why your migraine treatment may seem to not work: Incomplete diagnosis. There are different types of migraine. They each respond to different treatments. You may need to see a headache specialist who can correctly diagnose the type you have...
Volume 17, Issue 5, page 560, August 1997Additional Information How to Cite Dahlöf, C. (1997), Acute treatment of migraine with oral and subcutaneous sumatriptan. Cephalalgia, 17: 560. doi: 10.1046/j.1468-2982.1997.1705560-3.x Publication History Issue published online: 25 JAN 2002 Articl...
CGRP - a target for acute therapy in migraine: Clinical data The objective of the current study was to determine an effective and tolerable dose range of BMS-927711 for the acute treatment of migraine. In this randomized, double-blind, placebo controlled, dose-ranging study, 885... R Messina...
All patients with migraine need to be provided acute treatment, even those on preventive medications. Setting clinical goals and expectations with patients improves adherence and outcomes. Goals for acute treatment include quick onset with consistent response, low recurrence, restoration of normal function...